AbbVie Other intangible assets—net decreased by 3.4% to $50.87B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.0%, from $58.49B to $50.87B. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows a downward trend with a -8.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase typically signals recent strategic acquisitions or significant investment in R&D and intellectual property, while a decrease reflects ongoing amortization or potential impairment.
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software...
High in semiconductor and tech firms due to heavy reliance on patent portfolios and acquired technology.
non_current_assets_intangible_assets_net_excluding_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $79.34B | $77.46B | $75.95B | $73.99B | $71.82B | $68.73B | $67.44B | $64.85B | $62.86B | $58.60B | $55.61B | $62.23B | $60.24B | $66.65B | $60.07B | $58.49B | $57.03B | $54.32B | $52.64B | $50.87B |
| QoQ Change | — | -2.4% | -1.9% | -2.6% | -2.9% | -4.3% | -1.9% | -3.8% | -3.1% | -6.8% | -5.1% | +11.9% | -3.2% | +10.6% | -9.9% | -2.6% | -2.5% | -4.8% | -3.1% | -3.4% |
| YoY Change | — | — | — | — | -9.5% | -11.3% | -11.2% | -12.4% | -12.5% | -14.7% | -17.5% | -4.0% | -4.2% | +13.7% | +8.0% | -6.0% | -5.3% | -18.5% | -12.4% | -13.0% |